# Snap Inc. timeline entity: /record/snap.md id: ent_snap ## 2012 - 2012-05-01 | ceo | Evan Spiegel | valid | [clm_5E9ED6DDC5BD](/claim/clm_5E9ED6DDC5BD.md) ## 2013 - 2013-02-12 to 2016-05-26 | registrant_name | Snapchat Inc | superseded | [clm_E66F08910687](/claim/clm_E66F08910687.md) ## 2014 - 2014-12-31 to 2015-12-31 | cash_and_equivalents | 398,008,000 United States dollar | superseded | [clm_9CC1CC930B07](/claim/clm_9CC1CC930B07.md) ## 2015 - 2015-12-31 to 2016-03-31 | cash_and_equivalents | 640,810,000 United States dollar | superseded | [clm_EF80F4741F0B](/claim/clm_EF80F4741F0B.md) - 2015-12-31 to 2016-12-31 | net_income | -372,893,000 United States dollar | superseded | [clm_5C9DAB529037](/claim/clm_5C9DAB529037.md) - 2015-12-31 to 2016-12-31 | operating_income | -381,729,000 United States dollar | superseded | [clm_7FA139736394](/claim/clm_7FA139736394.md) - 2015-12-31 to 2016-12-31 | research_and_development | 82,235,000 United States dollar | superseded | [clm_6F8F13306B76](/claim/clm_6F8F13306B76.md) - 2015-12-31 to 2016-12-31 | revenue | 58,663,000 United States dollar | superseded | [clm_16291DCE9C67](/claim/clm_16291DCE9C67.md) - 2015-12-31 to 2016-12-31 | total_equity | 764,145,000 United States dollar | superseded | [clm_375D6E97555B](/claim/clm_375D6E97555B.md) ## 2016 - 2016-03-31 to 2016-06-30 | cash_and_equivalents | 514,987,000 United States dollar | superseded | [clm_8832F68A33D7](/claim/clm_8832F68A33D7.md) - 2016-03-31 to 2016-06-30 | quarterly_net_income | -104,576,000 United States dollar | superseded | [clm_5E4075448E20](/claim/clm_5E4075448E20.md) - 2016-03-31 to 2016-06-30 | quarterly_operating_income | -103,821,000 United States dollar | superseded | [clm_B80CE01BA424](/claim/clm_B80CE01BA424.md) - 2016-03-31 to 2016-06-30 | quarterly_research_and_development | 28,098,000 United States dollar | superseded | [clm_BE7C261BF3E9](/claim/clm_BE7C261BF3E9.md) - 2016-03-31 to 2016-06-30 | quarterly_revenue | 38,798,000 United States dollar | superseded | [clm_213FC05F15DD](/claim/clm_213FC05F15DD.md) - 2016-06-30 to 2016-09-30 | cash_and_equivalents | 587,970,000 United States dollar | superseded | [clm_B26E98AB4502](/claim/clm_B26E98AB4502.md) - 2016-06-30 to 2016-09-30 | quarterly_net_income | -115,894,000 United States dollar | superseded | [clm_C3308F65C5EE](/claim/clm_C3308F65C5EE.md) - 2016-06-30 to 2016-09-30 | quarterly_operating_income | -115,859,000 United States dollar | superseded | [clm_95606C19F57A](/claim/clm_95606C19F57A.md) - 2016-06-30 to 2016-09-30 | quarterly_research_and_development | 36,052,000 United States dollar | superseded | [clm_E5602BD6B696](/claim/clm_E5602BD6B696.md) - 2016-06-30 to 2016-09-30 | quarterly_revenue | 71,798,000 United States dollar | superseded | [clm_945C6CF7CD1A](/claim/clm_945C6CF7CD1A.md) - 2016-09-30 to 2016-12-31 | cash_and_equivalents | 203,452,000 United States dollar | superseded | [clm_F67DB294C185](/claim/clm_F67DB294C185.md) - 2016-09-30 to 2017-03-31 | quarterly_net_income | -124,228,000 United States dollar | superseded | [clm_E334B90EA634](/claim/clm_E334B90EA634.md) - 2016-09-30 to 2017-03-31 | quarterly_operating_income | -130,968,000 United States dollar | superseded | [clm_2FECBD30C6B4](/claim/clm_2FECBD30C6B4.md) - 2016-09-30 to 2017-03-31 | quarterly_research_and_development | 54,562,000 United States dollar | superseded | [clm_9FECDDF60988](/claim/clm_9FECDDF60988.md) - 2016-09-30 to 2017-03-31 | quarterly_revenue | 128,204,000 United States dollar | superseded | [clm_481768DCE7BE](/claim/clm_481768DCE7BE.md) - 2016-10-31 | registrant_name | Snap Inc | valid | [clm_8F58405DFA08](/claim/clm_8F58405DFA08.md) - 2016-12-31 to 2017-03-31 | cash_and_equivalents | 150,121,000 United States dollar | superseded | [clm_6EEFC7C6E98D](/claim/clm_6EEFC7C6E98D.md) - 2016-12-31 to 2017-12-31 | net_income | -514,643,000 United States dollar | superseded | [clm_41FF91F9FB52](/claim/clm_41FF91F9FB52.md) - 2016-12-31 to 2017-12-31 | operating_income | -520,385,000 United States dollar | superseded | [clm_01CE14FD7469](/claim/clm_01CE14FD7469.md) - 2016-12-31 to 2017-12-31 | research_and_development | 183,676,000 United States dollar | superseded | [clm_C22608F8EF97](/claim/clm_C22608F8EF97.md) - 2016-12-31 to 2017-12-31 | revenue | 404,482,000 United States dollar | superseded | [clm_F434508F7A5A](/claim/clm_F434508F7A5A.md) - 2016-12-31 to 2017-03-31 | total_assets | 1,722,792,000 United States dollar | superseded | [clm_B312B83B086E](/claim/clm_B312B83B086E.md) - 2016-12-31 to 2017-03-31 | total_equity | 1,518,914,000 United States dollar | superseded | [clm_B7A75E3E6417](/claim/clm_B7A75E3E6417.md) ## 2017 - 2017-03-31 to 2017-06-30 | cash_and_equivalents | 1,427,114,000 United States dollar | superseded | [clm_C5C73926B5BB](/claim/clm_C5C73926B5BB.md) - 2017-03-31 to 2017-06-30 | quarterly_net_income | -2,208,837,000 United States dollar | superseded | [clm_5B5D0DDED206](/claim/clm_5B5D0DDED206.md) - 2017-03-31 to 2017-06-30 | quarterly_operating_income | -2,213,767,000 United States dollar | superseded | [clm_3496DC6D281C](/claim/clm_3496DC6D281C.md) - 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 805,848,000 United States dollar | superseded | [clm_95F9500C5017](/claim/clm_95F9500C5017.md) - 2017-03-31 to 2017-06-30 | quarterly_revenue | 149,648,000 United States dollar | superseded | [clm_6E7A100FB1BF](/claim/clm_6E7A100FB1BF.md) - 2017-03-31 to 2017-06-30 | total_assets | 4,041,777,000 United States dollar | superseded | [clm_18541A14F648](/claim/clm_18541A14F648.md) - 2017-03-31 to 2017-06-30 | total_equity | 3,735,518,000 United States dollar | superseded | [clm_5FEFE85DB60F](/claim/clm_5FEFE85DB60F.md) - 2017-06-30 to 2017-09-30 | cash_and_equivalents | 501,677,000 United States dollar | superseded | [clm_3A129CD21D0D](/claim/clm_3A129CD21D0D.md) - 2017-06-30 to 2017-09-30 | quarterly_net_income | -443,093,000 United States dollar | superseded | [clm_3934D1E3C782](/claim/clm_3934D1E3C782.md) - 2017-06-30 to 2017-09-30 | quarterly_operating_income | -449,018,000 United States dollar | superseded | [clm_499091149F7F](/claim/clm_499091149F7F.md) - 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 255,735,000 United States dollar | superseded | [clm_4091FCE507CB](/claim/clm_4091FCE507CB.md) - 2017-06-30 to 2017-09-30 | quarterly_revenue | 181,671,000 United States dollar | superseded | [clm_1A1AB22E8E38](/claim/clm_1A1AB22E8E38.md) - 2017-06-30 to 2017-09-30 | total_assets | 3,875,474,000 United States dollar | superseded | [clm_7FEB8AC46618](/claim/clm_7FEB8AC46618.md) - 2017-06-30 to 2017-09-30 | total_equity | 3,540,907,000 United States dollar | superseded | [clm_800E8964AD19](/claim/clm_800E8964AD19.md) - 2017-09-30 to 2017-12-31 | cash_and_equivalents | 317,554,000 United States dollar | superseded | [clm_7EBE3D196E5F](/claim/clm_7EBE3D196E5F.md) - 2017-09-30 to 2018-03-31 | quarterly_net_income | -443,159,000 United States dollar | superseded | [clm_4B1CFA2986AA](/claim/clm_4B1CFA2986AA.md) - 2017-09-30 to 2018-03-31 | quarterly_operating_income | -461,827,000 United States dollar | superseded | [clm_4A1333A26A7A](/claim/clm_4A1333A26A7A.md) - 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 239,442,000 United States dollar | superseded | [clm_746224DE4C36](/claim/clm_746224DE4C36.md) - 2017-09-30 to 2018-03-31 | quarterly_revenue | 207,937,000 United States dollar | superseded | [clm_B72E363EC208](/claim/clm_B72E363EC208.md) - 2017-09-30 to 2017-12-31 | total_assets | 3,542,380,000 United States dollar | superseded | [clm_CF73C44EC380](/claim/clm_CF73C44EC380.md) - 2017-09-30 to 2017-12-31 | total_equity | 3,175,270,000 United States dollar | superseded | [clm_FD5D052C854B](/claim/clm_FD5D052C854B.md) - 2017-12-31 to 2018-03-31 | cash_and_equivalents | 334,063,000 United States dollar | superseded | [clm_F2086E032B16](/claim/clm_F2086E032B16.md) - 2017-12-31 to 2018-12-31 | net_income | -3,445,066,000 United States dollar | superseded | [clm_64ABE7D60E86](/claim/clm_64ABE7D60E86.md) - 2017-12-31 to 2018-12-31 | operating_income | -3,485,576,000 United States dollar | superseded | [clm_8AD4C5A7AE6B](/claim/clm_8AD4C5A7AE6B.md) - 2017-12-31 to 2018-12-31 | research_and_development | 1,534,863,000 United States dollar | superseded | [clm_59DEFBBD94F9](/claim/clm_59DEFBBD94F9.md) - 2017-12-31 to 2018-12-31 | revenue | 824,949,000 United States dollar | superseded | [clm_BAF5FDB64FDE](/claim/clm_BAF5FDB64FDE.md) - 2017-12-31 to 2018-03-31 | total_assets | 3,421,566,000 United States dollar | superseded | [clm_3A796EB0FE7E](/claim/clm_3A796EB0FE7E.md) - 2017-12-31 to 2018-03-31 | total_equity | 2,992,327,000 United States dollar | superseded | [clm_A91BCE090F11](/claim/clm_A91BCE090F11.md) ## 2018 - 2018-03-31 to 2018-06-30 | cash_and_equivalents | 466,323,000 United States dollar | superseded | [clm_4CA4D1C7CFBD](/claim/clm_4CA4D1C7CFBD.md) - 2018-03-31 to 2018-06-30 | quarterly_net_income | -385,785,000 United States dollar | superseded | [clm_12EADA31C36C](/claim/clm_12EADA31C36C.md) - 2018-03-31 to 2018-06-30 | quarterly_operating_income | -392,530,000 United States dollar | superseded | [clm_C716387D656D](/claim/clm_C716387D656D.md) - 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 200,986,000 United States dollar | superseded | [clm_6B0B7DDF539E](/claim/clm_6B0B7DDF539E.md) - 2018-03-31 to 2018-06-30 | quarterly_revenue | 230,666,000 United States dollar | superseded | [clm_E8BDE386C28D](/claim/clm_E8BDE386C28D.md) - 2018-03-31 to 2018-06-30 | total_assets | 3,182,030,000 United States dollar | superseded | [clm_F3AC881BB658](/claim/clm_F3AC881BB658.md) - 2018-03-31 to 2018-06-30 | total_equity | 2,791,848,000 United States dollar | superseded | [clm_3061CD80B686](/claim/clm_3061CD80B686.md) - 2018-06-30 to 2018-09-30 | cash_and_equivalents | 393,183,000 United States dollar | superseded | [clm_00103BC9493B](/claim/clm_00103BC9493B.md) - 2018-06-30 to 2018-09-30 | quarterly_net_income | -353,310,000 United States dollar | superseded | [clm_804CBBCE63E8](/claim/clm_804CBBCE63E8.md) - 2018-06-30 to 2018-09-30 | quarterly_operating_income | -357,842,000 United States dollar | superseded | [clm_93C50B3C9458](/claim/clm_93C50B3C9458.md) - 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 203,246,000 United States dollar | superseded | [clm_E0D5FBC21CAD](/claim/clm_E0D5FBC21CAD.md) - 2018-06-30 to 2018-09-30 | quarterly_revenue | 262,263,000 United States dollar | superseded | [clm_A0DEE04A4596](/claim/clm_A0DEE04A4596.md) - 2018-06-30 to 2018-09-30 | total_assets | 2,950,713,000 United States dollar | superseded | [clm_57EA3FADCDE8](/claim/clm_57EA3FADCDE8.md) - 2018-06-30 to 2018-09-30 | total_equity | 2,584,068,000 United States dollar | superseded | [clm_09072467A44B](/claim/clm_09072467A44B.md) - 2018-09-30 to 2018-12-31 | cash_and_equivalents | 350,398,000 United States dollar | superseded | [clm_33CFF69A1C4B](/claim/clm_33CFF69A1C4B.md) - 2018-09-30 to 2019-03-31 | quarterly_net_income | -325,148,000 United States dollar | superseded | [clm_2303E66609F5](/claim/clm_2303E66609F5.md) - 2018-09-30 to 2019-03-31 | quarterly_operating_income | -323,371,000 United States dollar | superseded | [clm_559AEF9EF451](/claim/clm_559AEF9EF451.md) - 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 203,510,000 United States dollar | superseded | [clm_4ED32F2BCE27](/claim/clm_4ED32F2BCE27.md) - 2018-09-30 to 2019-03-31 | quarterly_revenue | 297,695,000 United States dollar | superseded | [clm_C77E2D999862](/claim/clm_C77E2D999862.md) - 2018-09-30 to 2018-12-31 | total_assets | 2,783,776,000 United States dollar | superseded | [clm_C3981FAABDDA](/claim/clm_C3981FAABDDA.md) - 2018-09-30 to 2018-12-31 | total_equity | 2,384,092,000 United States dollar | superseded | [clm_D5BF2975496B](/claim/clm_D5BF2975496B.md) - 2018-12-31 to 2019-03-31 | cash_and_equivalents | 387,149,000 United States dollar | superseded | [clm_C83A97B31581](/claim/clm_C83A97B31581.md) - 2018-12-31 to 2019-12-31 | net_income | -1,255,911,000 United States dollar | superseded | [clm_1B13CC04B44D](/claim/clm_1B13CC04B44D.md) - 2018-12-31 to 2019-12-31 | operating_income | -1,268,450,000 United States dollar | superseded | [clm_F0C22290CC65](/claim/clm_F0C22290CC65.md) - 2018-12-31 to 2019-12-31 | research_and_development | 772,185,000 United States dollar | superseded | [clm_203EBCA928EF](/claim/clm_203EBCA928EF.md) - 2018-12-31 to 2019-12-31 | revenue | 1,180,446,000 United States dollar | superseded | [clm_78BB805CDAF0](/claim/clm_78BB805CDAF0.md) - 2018-12-31 to 2019-03-31 | total_assets | 2,714,106,000 United States dollar | superseded | [clm_D03E4A501886](/claim/clm_D03E4A501886.md) - 2018-12-31 to 2019-03-31 | total_equity | 2,310,999,000 United States dollar | superseded | [clm_E217C02AFF59](/claim/clm_E217C02AFF59.md) ## 2019 - 2019-03-31 to 2019-06-30 | cash_and_equivalents | 245,639,000 United States dollar | superseded | [clm_7D774DDF93D1](/claim/clm_7D774DDF93D1.md) - 2019-03-31 to 2019-06-30 | quarterly_net_income | -310,407,000 United States dollar | superseded | [clm_0FDF9E475F07](/claim/clm_0FDF9E475F07.md) - 2019-03-31 to 2019-06-30 | quarterly_operating_income | -316,061,000 United States dollar | superseded | [clm_ECAEB5446900](/claim/clm_ECAEB5446900.md) - 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 216,185,000 United States dollar | superseded | [clm_545E28FD1393](/claim/clm_545E28FD1393.md) - 2019-03-31 to 2019-06-30 | quarterly_revenue | 320,426,000 United States dollar | superseded | [clm_1B430CE01A72](/claim/clm_1B430CE01A72.md) - 2019-03-31 to 2019-06-30 | total_assets | 2,825,743,000 United States dollar | superseded | [clm_487B387ADEA3](/claim/clm_487B387ADEA3.md) - 2019-03-31 to 2019-06-30 | total_equity | 2,165,877,000 United States dollar | superseded | [clm_A3068A29BB9E](/claim/clm_A3068A29BB9E.md) - 2019-06-30 to 2019-09-30 | cash_and_equivalents | 335,744,000 United States dollar | superseded | [clm_E9F8EC32A5B2](/claim/clm_E9F8EC32A5B2.md) - 2019-06-30 to 2019-09-30 | quarterly_net_income | -255,174,000 United States dollar | superseded | [clm_2B0A1EBEF420](/claim/clm_2B0A1EBEF420.md) - 2019-06-30 to 2019-09-30 | quarterly_operating_income | -304,818,000 United States dollar | superseded | [clm_A1EC43AF367B](/claim/clm_A1EC43AF367B.md) - 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 236,199,000 United States dollar | superseded | [clm_9E3718EF7357](/claim/clm_9E3718EF7357.md) - 2019-06-30 to 2019-09-30 | quarterly_revenue | 388,021,000 United States dollar | superseded | [clm_C03E6952AAB9](/claim/clm_C03E6952AAB9.md) - 2019-06-30 to 2019-09-30 | total_assets | 2,776,025,000 United States dollar | superseded | [clm_0C35A0DA522D](/claim/clm_0C35A0DA522D.md) - 2019-06-30 to 2019-09-30 | total_equity | 2,116,698,000 United States dollar | superseded | [clm_1A91563E912C](/claim/clm_1A91563E912C.md) - 2019-09-30 to 2019-12-31 | cash_and_equivalents | 728,828,000 United States dollar | superseded | [clm_7F33B9B779C3](/claim/clm_7F33B9B779C3.md) - 2019-09-30 to 2020-03-31 | quarterly_net_income | -227,375,000 United States dollar | superseded | [clm_AA1B970D4461](/claim/clm_AA1B970D4461.md) - 2019-09-30 to 2020-03-31 | quarterly_operating_income | -228,853,000 United States dollar | superseded | [clm_0A5814339768](/claim/clm_0A5814339768.md) - 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 211,599,000 United States dollar | superseded | [clm_593EC98FFA9C](/claim/clm_593EC98FFA9C.md) - 2019-09-30 to 2020-03-31 | quarterly_revenue | 446,199,000 United States dollar | superseded | [clm_18096BCD4C1D](/claim/clm_18096BCD4C1D.md) - 2019-09-30 to 2019-12-31 | total_assets | 3,864,372,000 United States dollar | superseded | [clm_C463A1FB60F1](/claim/clm_C463A1FB60F1.md) - 2019-09-30 to 2019-12-31 | total_equity | 2,324,415,000 United States dollar | superseded | [clm_76182ADFFCB9](/claim/clm_76182ADFFCB9.md) - 2019-12-31 to 2020-03-31 | cash_and_equivalents | 520,317,000 United States dollar | superseded | [clm_482BF292E5C9](/claim/clm_482BF292E5C9.md) - 2019-12-31 to 2020-12-31 | net_income | -1,033,660,000 United States dollar | superseded | [clm_5F3A0A03D8B3](/claim/clm_5F3A0A03D8B3.md) - 2019-12-31 to 2020-12-31 | operating_income | -1,103,328,000 United States dollar | superseded | [clm_559A74287626](/claim/clm_559A74287626.md) - 2019-12-31 to 2020-12-31 | research_and_development | 883,509,000 United States dollar | superseded | [clm_E3E204E7253B](/claim/clm_E3E204E7253B.md) - 2019-12-31 to 2020-12-31 | revenue | 1,715,534,000 United States dollar | superseded | [clm_E746BB085FBE](/claim/clm_E746BB085FBE.md) - 2019-12-31 to 2020-03-31 | total_assets | 4,011,924,000 United States dollar | superseded | [clm_16B8CB405771](/claim/clm_16B8CB405771.md) - 2019-12-31 to 2020-03-31 | total_equity | 2,259,913,000 United States dollar | superseded | [clm_A54E4E436A50](/claim/clm_A54E4E436A50.md) ## 2020 - 2020-03-31 to 2020-06-30 | cash_and_equivalents | 901,342,000 United States dollar | superseded | [clm_F77894102694](/claim/clm_F77894102694.md) - 2020-03-31 to 2020-06-30 | quarterly_net_income | -305,936,000 United States dollar | superseded | [clm_F3AFDE9833F5](/claim/clm_F3AFDE9833F5.md) - 2020-03-31 to 2020-06-30 | quarterly_operating_income | -286,364,000 United States dollar | superseded | [clm_910E61AFAFEA](/claim/clm_910E61AFAFEA.md) - 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 238,613,000 United States dollar | superseded | [clm_358F0D19A448](/claim/clm_358F0D19A448.md) - 2020-03-31 to 2020-06-30 | quarterly_revenue | 462,478,000 United States dollar | superseded | [clm_A97E417F1388](/claim/clm_A97E417F1388.md) - 2020-03-31 to 2020-06-30 | total_assets | 3,898,510,000 United States dollar | superseded | [clm_120B92B98B7C](/claim/clm_120B92B98B7C.md) - 2020-03-31 to 2020-06-30 | total_equity | 2,124,907,000 United States dollar | superseded | [clm_F755B12D168E](/claim/clm_F755B12D168E.md) - 2020-06-30 to 2020-09-30 | cash_and_equivalents | 1,251,721,000 United States dollar | superseded | [clm_79EA6FB2080F](/claim/clm_79EA6FB2080F.md) - 2020-06-30 to 2020-09-30 | quarterly_net_income | -325,951,000 United States dollar | superseded | [clm_BFC586CF1B3C](/claim/clm_BFC586CF1B3C.md) - 2020-06-30 to 2020-09-30 | quarterly_operating_income | -310,608,000 United States dollar | superseded | [clm_1D72D2D45A82](/claim/clm_1D72D2D45A82.md) - 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 260,863,000 United States dollar | superseded | [clm_5F65E17C7EA6](/claim/clm_5F65E17C7EA6.md) - 2020-06-30 to 2020-09-30 | quarterly_revenue | 454,158,000 United States dollar | superseded | [clm_6C33C484854B](/claim/clm_6C33C484854B.md) - 2020-06-30 to 2020-09-30 | total_assets | 4,704,029,000 United States dollar | superseded | [clm_CA7FE32EB790](/claim/clm_CA7FE32EB790.md) - 2020-06-30 to 2020-09-30 | total_equity | 2,194,665,000 United States dollar | superseded | [clm_1D98810BD8AA](/claim/clm_1D98810BD8AA.md) - 2020-09-30 to 2020-12-31 | cash_and_equivalents | 824,070,000 United States dollar | superseded | [clm_F388B62A6A9E](/claim/clm_F388B62A6A9E.md) - 2020-09-30 to 2021-03-31 | quarterly_net_income | -199,853,000 United States dollar | superseded | [clm_64ABEA7B6B6E](/claim/clm_64ABEA7B6B6E.md) - 2020-09-30 to 2021-03-31 | quarterly_operating_income | -167,864,000 United States dollar | superseded | [clm_4A4ADDC2FA46](/claim/clm_4A4ADDC2FA46.md) - 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 283,639,000 United States dollar | superseded | [clm_FB548DDD9838](/claim/clm_FB548DDD9838.md) - 2020-09-30 to 2021-03-31 | quarterly_revenue | 678,668,000 United States dollar | superseded | [clm_5F9FFDA64C06](/claim/clm_5F9FFDA64C06.md) - 2020-09-30 to 2020-12-31 | total_assets | 4,817,774,000 United States dollar | superseded | [clm_FFEB76951858](/claim/clm_FFEB76951858.md) - 2020-09-30 to 2020-12-31 | total_equity | 2,198,771,000 United States dollar | superseded | [clm_5E0440A96F4B](/claim/clm_5E0440A96F4B.md) - 2020-12-31 to 2021-03-31 | cash_and_equivalents | 545,618,000 United States dollar | superseded | [clm_58C8A41B12CF](/claim/clm_58C8A41B12CF.md) - 2020-12-31 to 2021-12-31 | net_income | -944,839,000 United States dollar | superseded | [clm_50A5C0008BFC](/claim/clm_50A5C0008BFC.md) - 2020-12-31 to 2021-12-31 | operating_income | -862,072,000 United States dollar | superseded | [clm_095CC7F05097](/claim/clm_095CC7F05097.md) - 2020-12-31 to 2021-12-31 | research_and_development | 1,101,561,000 United States dollar | superseded | [clm_DBBAD95756EB](/claim/clm_DBBAD95756EB.md) - 2020-12-31 to 2021-12-31 | revenue | 2,506,626,000 United States dollar | superseded | [clm_5BCFD2D7EF13](/claim/clm_5BCFD2D7EF13.md) - 2020-12-31 to 2021-03-31 | total_assets | 5,024,238,000 United States dollar | superseded | [clm_5F24B14C14D7](/claim/clm_5F24B14C14D7.md) - 2020-12-31 to 2021-03-31 | total_equity | 2,329,976,000 United States dollar | superseded | [clm_9F542892FA2B](/claim/clm_9F542892FA2B.md) ## 2021 - 2021-03-31 to 2021-06-30 | cash_and_equivalents | 967,519,000 United States dollar | superseded | [clm_B3061BFA4727](/claim/clm_B3061BFA4727.md) - 2021-03-31 to 2021-06-30 | quarterly_net_income | -286,882,000 United States dollar | superseded | [clm_91A41AAEF6D4](/claim/clm_91A41AAEF6D4.md) - 2021-03-31 to 2021-06-30 | quarterly_operating_income | -303,606,000 United States dollar | superseded | [clm_800970548975](/claim/clm_800970548975.md) - 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 348,580,000 United States dollar | superseded | [clm_D6760B0A2098](/claim/clm_D6760B0A2098.md) - 2021-03-31 to 2021-06-30 | quarterly_revenue | 769,584,000 United States dollar | superseded | [clm_0FE11D74AD9B](/claim/clm_0FE11D74AD9B.md) - 2021-03-31 to 2021-06-30 | total_assets | 5,058,780,000 United States dollar | superseded | [clm_4FC033F4C198](/claim/clm_4FC033F4C198.md) - 2021-03-31 to 2021-06-30 | total_equity | 1,706,178,000 United States dollar | superseded | [clm_306A73DEB13E](/claim/clm_306A73DEB13E.md) - 2021-06-30 to 2021-09-30 | cash_and_equivalents | 2,051,961,000 United States dollar | superseded | [clm_9F69BEA00D01](/claim/clm_9F69BEA00D01.md) - 2021-06-30 to 2021-09-30 | quarterly_net_income | -151,664,000 United States dollar | superseded | [clm_4A9B058A3023](/claim/clm_4A9B058A3023.md) - 2021-06-30 to 2021-09-30 | quarterly_operating_income | -192,512,000 United States dollar | superseded | [clm_3F72A253F69C](/claim/clm_3F72A253F69C.md) - 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 370,671,000 United States dollar | superseded | [clm_95D250CF9C36](/claim/clm_95D250CF9C36.md) - 2021-06-30 to 2021-09-30 | quarterly_revenue | 982,108,000 United States dollar | superseded | [clm_977E8AD19FB1](/claim/clm_977E8AD19FB1.md) - 2021-06-30 to 2021-09-30 | total_assets | 6,820,815,000 United States dollar | superseded | [clm_E0281A487AA8](/claim/clm_E0281A487AA8.md) - 2021-06-30 to 2021-09-30 | total_equity | 2,908,001,000 United States dollar | superseded | [clm_550525E075B7](/claim/clm_550525E075B7.md) - 2021-09-30 to 2021-12-31 | cash_and_equivalents | 1,972,358,000 United States dollar | superseded | [clm_2CFCC5242DC3](/claim/clm_2CFCC5242DC3.md) - 2021-09-30 to 2022-03-31 | quarterly_net_income | -71,959,000 United States dollar | superseded | [clm_279C4FB2B8D1](/claim/clm_279C4FB2B8D1.md) - 2021-09-30 to 2022-03-31 | quarterly_operating_income | -180,824,000 United States dollar | superseded | [clm_1A29557E3BE5](/claim/clm_1A29557E3BE5.md) - 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 412,021,000 United States dollar | superseded | [clm_2916E8866706](/claim/clm_2916E8866706.md) - 2021-09-30 to 2022-03-31 | quarterly_revenue | 1,067,471,000 United States dollar | superseded | [clm_53A910B775BF](/claim/clm_53A910B775BF.md) - 2021-09-30 to 2021-12-31 | total_assets | 7,111,165,000 United States dollar | superseded | [clm_9006B5482567](/claim/clm_9006B5482567.md) - 2021-09-30 to 2021-12-31 | total_equity | 3,440,116,000 United States dollar | superseded | [clm_2CE3AFB04A05](/claim/clm_2CE3AFB04A05.md) - 2021-12-31 to 2022-03-31 | cash_and_equivalents | 1,993,809,000 United States dollar | superseded | [clm_4F6B9479E337](/claim/clm_4F6B9479E337.md) - 2021-12-31 to 2022-12-31 | net_income | -487,955,000 United States dollar | superseded | [clm_C0A0EEA3FB0A](/claim/clm_C0A0EEA3FB0A.md) - 2021-12-31 to 2022-12-31 | operating_income | -702,069,000 United States dollar | superseded | [clm_2DD65078E278](/claim/clm_2DD65078E278.md) - 2021-12-31 to 2022-12-31 | research_and_development | 1,565,467,000 United States dollar | superseded | [clm_533CC37660A1](/claim/clm_533CC37660A1.md) - 2021-12-31 to 2022-12-31 | revenue | 4,117,048,000 United States dollar | superseded | [clm_E0E7A12B2219](/claim/clm_E0E7A12B2219.md) - 2021-12-31 to 2022-03-31 | total_assets | 7,536,306,000 United States dollar | superseded | [clm_1DC6FFC39CD6](/claim/clm_1DC6FFC39CD6.md) - 2021-12-31 to 2022-03-31 | total_equity | 3,790,168,000 United States dollar | superseded | [clm_62E186C711AF](/claim/clm_62E186C711AF.md) ## 2022 - 2022-03-31 to 2022-06-30 | cash_and_equivalents | 2,412,372,000 United States dollar | superseded | [clm_E67CDBA431E5](/claim/clm_E67CDBA431E5.md) - 2022-03-31 to 2022-06-30 | quarterly_net_income | -359,624,000 United States dollar | superseded | [clm_4AAB70D2BD9A](/claim/clm_4AAB70D2BD9A.md) - 2022-03-31 to 2022-06-30 | quarterly_operating_income | -271,527,000 United States dollar | superseded | [clm_F741354DAFFA](/claim/clm_F741354DAFFA.md) - 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 455,563,000 United States dollar | superseded | [clm_0A9019668E87](/claim/clm_0A9019668E87.md) - 2022-03-31 to 2022-06-30 | quarterly_revenue | 1,062,727,000 United States dollar | superseded | [clm_D6E6B3A94C82](/claim/clm_D6E6B3A94C82.md) - 2022-03-31 to 2022-06-30 | total_assets | 8,944,937,000 United States dollar | superseded | [clm_4119C3D6E769](/claim/clm_4119C3D6E769.md) - 2022-03-31 to 2022-06-30 | total_equity | 3,563,036,000 United States dollar | superseded | [clm_E0F534F76EF5](/claim/clm_E0F534F76EF5.md) - 2022-06-30 to 2022-09-30 | cash_and_equivalents | 2,298,122,000 United States dollar | superseded | [clm_08DFB77BCE48](/claim/clm_08DFB77BCE48.md) - 2022-06-30 to 2022-09-30 | quarterly_net_income | -422,067,000 United States dollar | superseded | [clm_A60BC1E68CB6](/claim/clm_A60BC1E68CB6.md) - 2022-06-30 to 2022-09-30 | quarterly_operating_income | -400,940,000 United States dollar | superseded | [clm_F1AE3CE05F9D](/claim/clm_F1AE3CE05F9D.md) - 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 505,037,000 United States dollar | superseded | [clm_ABE269586DCA](/claim/clm_ABE269586DCA.md) - 2022-06-30 to 2022-09-30 | quarterly_revenue | 1,110,909,000 United States dollar | superseded | [clm_62B02C1416EF](/claim/clm_62B02C1416EF.md) - 2022-06-30 to 2022-09-30 | total_assets | 8,790,791,000 United States dollar | superseded | [clm_FA7A0EEB2742](/claim/clm_FA7A0EEB2742.md) - 2022-06-30 to 2022-09-30 | total_equity | 3,443,759,000 United States dollar | superseded | [clm_E0B96ED30F1D](/claim/clm_E0B96ED30F1D.md) - 2022-09-30 to 2022-12-31 | cash_and_equivalents | 1,918,845,000 United States dollar | superseded | [clm_59EA6C7538B7](/claim/clm_59EA6C7538B7.md) - 2022-09-30 to 2023-03-31 | quarterly_net_income | -359,502,000 United States dollar | superseded | [clm_A219F618E36F](/claim/clm_A219F618E36F.md) - 2022-09-30 to 2023-03-31 | quarterly_operating_income | -435,242,000 United States dollar | superseded | [clm_0AD8ED24CA66](/claim/clm_0AD8ED24CA66.md) - 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 564,258,000 United States dollar | superseded | [clm_CD78EF37C9F6](/claim/clm_CD78EF37C9F6.md) - 2022-09-30 to 2023-03-31 | quarterly_revenue | 1,128,476,000 United States dollar | superseded | [clm_5B6E16FBF8FC](/claim/clm_5B6E16FBF8FC.md) - 2022-09-30 to 2022-12-31 | total_assets | 8,285,194,000 United States dollar | superseded | [clm_DAD4AE45258C](/claim/clm_DAD4AE45258C.md) - 2022-09-30 to 2022-12-31 | total_equity | 2,900,262,000 United States dollar | superseded | [clm_6F2EEDBBEDF0](/claim/clm_6F2EEDBBEDF0.md) - 2022-12-31 to 2023-03-31 | cash_and_equivalents | 1,423,121,000 United States dollar | superseded | [clm_1CCBB16EC42D](/claim/clm_1CCBB16EC42D.md) - 2022-12-31 to 2023-12-31 | net_income | -1,429,653,000 United States dollar | superseded | [clm_30343FFFF280](/claim/clm_30343FFFF280.md) - 2022-12-31 to 2023-12-31 | operating_income | -1,395,306,000 United States dollar | superseded | [clm_F08B9DE9CC02](/claim/clm_F08B9DE9CC02.md) - 2022-12-31 to 2023-12-31 | research_and_development | 2,109,800,000 United States dollar | superseded | [clm_B3F6BDCB7F84](/claim/clm_B3F6BDCB7F84.md) - 2022-12-31 to 2023-12-31 | revenue | 4,601,847,000 United States dollar | superseded | [clm_3D83AC8074B6](/claim/clm_3D83AC8074B6.md) - 2022-12-31 to 2023-03-31 | total_assets | 8,029,538,000 United States dollar | superseded | [clm_600742D33F2D](/claim/clm_600742D33F2D.md) - 2022-12-31 to 2023-03-31 | total_equity | 2,580,698,000 United States dollar | superseded | [clm_2BC01B7C65D2](/claim/clm_2BC01B7C65D2.md) ## 2023 - 2023-03-31 to 2023-06-30 | cash_and_equivalents | 1,578,528,000 United States dollar | superseded | [clm_B35C572EDA1B](/claim/clm_B35C572EDA1B.md) - 2023-03-31 to 2023-06-30 | quarterly_net_income | -328,674,000 United States dollar | superseded | [clm_E7039988F377](/claim/clm_E7039988F377.md) - 2023-03-31 to 2023-06-30 | quarterly_operating_income | -365,264,000 United States dollar | superseded | [clm_58E8B0A21E72](/claim/clm_58E8B0A21E72.md) - 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 455,112,000 United States dollar | superseded | [clm_ECE94BA42DB6](/claim/clm_ECE94BA42DB6.md) - 2023-03-31 to 2023-06-30 | quarterly_revenue | 988,608,000 United States dollar | superseded | [clm_0F30DC19A684](/claim/clm_0F30DC19A684.md) - 2023-03-31 to 2023-06-30 | total_assets | 7,888,390,000 United States dollar | superseded | [clm_DEF28A0AB5AB](/claim/clm_DEF28A0AB5AB.md) - 2023-03-31 to 2023-06-30 | total_equity | 2,578,440,000 United States dollar | superseded | [clm_1D1DB665FCC6](/claim/clm_1D1DB665FCC6.md) - 2023-06-30 to 2023-09-30 | cash_and_equivalents | 1,228,629,000 United States dollar | superseded | [clm_D0E5AE28C41E](/claim/clm_D0E5AE28C41E.md) - 2023-06-30 to 2023-09-30 | quarterly_net_income | -377,308,000 United States dollar | superseded | [clm_2F1B548E1870](/claim/clm_2F1B548E1870.md) - 2023-06-30 to 2023-09-30 | quarterly_operating_income | -404,339,000 United States dollar | superseded | [clm_5F0334BB4493](/claim/clm_5F0334BB4493.md) - 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 477,663,000 United States dollar | superseded | [clm_881B79A515EC](/claim/clm_881B79A515EC.md) - 2023-06-30 to 2023-09-30 | quarterly_revenue | 1,067,669,000 United States dollar | superseded | [clm_E3BAD0ECC77D](/claim/clm_E3BAD0ECC77D.md) - 2023-06-30 to 2023-09-30 | total_assets | 7,666,223,000 United States dollar | superseded | [clm_2FC972D1625F](/claim/clm_2FC972D1625F.md) - 2023-06-30 to 2023-09-30 | total_equity | 2,504,960,000 United States dollar | superseded | [clm_4E52269E98C9](/claim/clm_4E52269E98C9.md) - 2023-09-30 to 2023-12-31 | cash_and_equivalents | 1,199,366,000 United States dollar | superseded | [clm_156D30DDB0EE](/claim/clm_156D30DDB0EE.md) - 2023-09-30 to 2024-03-31 | quarterly_net_income | -368,256,000 United States dollar | superseded | [clm_04846C82EC1C](/claim/clm_04846C82EC1C.md) - 2023-09-30 to 2024-03-31 | quarterly_operating_income | -380,063,000 United States dollar | superseded | [clm_A119047AD956](/claim/clm_A119047AD956.md) - 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 494,559,000 United States dollar | superseded | [clm_18F3F623FEC2](/claim/clm_18F3F623FEC2.md) - 2023-09-30 to 2024-03-31 | quarterly_revenue | 1,188,551,000 United States dollar | superseded | [clm_DEDEECAA56B7](/claim/clm_DEDEECAA56B7.md) - 2023-09-30 to 2023-12-31 | total_assets | 7,722,905,000 United States dollar | superseded | [clm_072D4D189156](/claim/clm_072D4D189156.md) - 2023-09-30 to 2023-12-31 | total_equity | 2,493,021,000 United States dollar | superseded | [clm_8C30983696DE](/claim/clm_8C30983696DE.md) - 2023-12-31 to 2024-03-31 | cash_and_equivalents | 1,780,400,000 United States dollar | superseded | [clm_2E2A1C959F59](/claim/clm_2E2A1C959F59.md) - 2023-12-31 to 2024-12-31 | net_income | -1,322,485,000 United States dollar | superseded | [clm_D96AF74317D5](/claim/clm_D96AF74317D5.md) - 2023-12-31 to 2024-12-31 | operating_income | -1,398,379,000 United States dollar | superseded | [clm_08B1267A7A82](/claim/clm_08B1267A7A82.md) - 2023-12-31 to 2024-12-31 | research_and_development | 1,910,862,000 United States dollar | superseded | [clm_65C4AB0927D4](/claim/clm_65C4AB0927D4.md) - 2023-12-31 to 2024-12-31 | revenue | 4,606,115,000 United States dollar | superseded | [clm_41BAB967F34C](/claim/clm_41BAB967F34C.md) - 2023-12-31 to 2024-03-31 | total_assets | 7,967,758,000 United States dollar | superseded | [clm_47EF93C3FFB4](/claim/clm_47EF93C3FFB4.md) - 2023-12-31 to 2024-03-31 | total_equity | 2,414,112,000 United States dollar | superseded | [clm_27D4EE5BC9FD](/claim/clm_27D4EE5BC9FD.md) ## 2024 - 2024-03-31 to 2024-06-30 | cash_and_equivalents | 1,060,393,000 United States dollar | superseded | [clm_F3375DCB4EA7](/claim/clm_F3375DCB4EA7.md) - 2024-03-31 to 2024-06-30 | quarterly_net_income | -305,090,000 United States dollar | superseded | [clm_DB07ECB2D425](/claim/clm_DB07ECB2D425.md) - 2024-03-31 to 2024-06-30 | quarterly_operating_income | -333,232,000 United States dollar | superseded | [clm_068B39325C66](/claim/clm_068B39325C66.md) - 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 449,759,000 United States dollar | superseded | [clm_621C73D5D72C](/claim/clm_621C73D5D72C.md) - 2024-03-31 to 2024-06-30 | quarterly_revenue | 1,194,773,000 United States dollar | superseded | [clm_554043D0468A](/claim/clm_554043D0468A.md) - 2024-03-31 to 2024-06-30 | total_assets | 7,167,401,000 United States dollar | superseded | [clm_A5B1668B5A5B](/claim/clm_A5B1668B5A5B.md) - 2024-03-31 to 2024-06-30 | total_equity | 2,131,348,000 United States dollar | superseded | [clm_11F7D0095E7B](/claim/clm_11F7D0095E7B.md) - 2024-06-30 to 2024-09-30 | cash_and_equivalents | 1,060,551,000 United States dollar | superseded | [clm_18F279D11DC3](/claim/clm_18F279D11DC3.md) - 2024-06-30 to 2024-09-30 | quarterly_net_income | -248,620,000 United States dollar | superseded | [clm_51AB07DD5C9E](/claim/clm_51AB07DD5C9E.md) - 2024-06-30 to 2024-09-30 | quarterly_operating_income | -253,975,000 United States dollar | superseded | [clm_7186F4868E2F](/claim/clm_7186F4868E2F.md) - 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 406,196,000 United States dollar | superseded | [clm_A3B113B38E2C](/claim/clm_A3B113B38E2C.md) - 2024-06-30 to 2024-09-30 | quarterly_revenue | 1,236,768,000 United States dollar | superseded | [clm_D7DD3CBFA84C](/claim/clm_D7DD3CBFA84C.md) - 2024-06-30 to 2024-09-30 | total_assets | 7,420,039,000 United States dollar | superseded | [clm_A044A211AD1E](/claim/clm_A044A211AD1E.md) - 2024-06-30 to 2024-09-30 | total_equity | 2,066,722,000 United States dollar | superseded | [clm_089C00C4AA0B](/claim/clm_089C00C4AA0B.md) - 2024-09-30 to 2024-12-31 | cash_and_equivalents | 964,967,000 United States dollar | superseded | [clm_3EB235C539EE](/claim/clm_3EB235C539EE.md) - 2024-09-30 to 2025-03-31 | quarterly_net_income | -153,247,000 United States dollar | superseded | [clm_CDBC26AD8D94](/claim/clm_CDBC26AD8D94.md) - 2024-09-30 to 2025-03-31 | quarterly_operating_income | -173,210,000 United States dollar | superseded | [clm_B20D60D682D0](/claim/clm_B20D60D682D0.md) - 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 412,791,000 United States dollar | superseded | [clm_A4934F6CFF5F](/claim/clm_A4934F6CFF5F.md) - 2024-09-30 to 2025-03-31 | quarterly_revenue | 1,372,574,000 United States dollar | superseded | [clm_002A0D885617](/claim/clm_002A0D885617.md) - 2024-09-30 to 2024-12-31 | total_assets | 7,591,417,000 United States dollar | superseded | [clm_BA045E001074](/claim/clm_BA045E001074.md) - 2024-09-30 to 2024-12-31 | total_equity | 2,210,075,000 United States dollar | superseded | [clm_72775F2F2C65](/claim/clm_72775F2F2C65.md) - 2024-12-31 to 2025-03-31 | cash_and_equivalents | 1,046,534,000 United States dollar | superseded | [clm_7C64F30ABA6E](/claim/clm_7C64F30ABA6E.md) - 2024-12-31 to 2025-12-31 | net_income | -697,856,000 United States dollar | superseded | [clm_75EC092B683B](/claim/clm_75EC092B683B.md) - 2024-12-31 to 2025-12-31 | operating_income | -787,294,000 United States dollar | superseded | [clm_C6C85F2860DE](/claim/clm_C6C85F2860DE.md) - 2024-12-31 to 2025-12-31 | research_and_development | 1,691,683,000 United States dollar | superseded | [clm_D3CCA5E89073](/claim/clm_D3CCA5E89073.md) - 2024-12-31 to 2025-12-31 | revenue | 5,361,398,000 United States dollar | superseded | [clm_235FBCB7F12E](/claim/clm_235FBCB7F12E.md) - 2024-12-31 to 2025-03-31 | total_assets | 7,936,348,000 United States dollar | superseded | [clm_A78297D5EB36](/claim/clm_A78297D5EB36.md) - 2024-12-31 to 2025-03-31 | total_equity | 2,450,761,000 United States dollar | superseded | [clm_58FF18E6D433](/claim/clm_58FF18E6D433.md) ## 2025 - 2025-03-31 to 2025-06-30 | cash_and_equivalents | 911,227,000 United States dollar | superseded | [clm_69AAD5ADBA52](/claim/clm_69AAD5ADBA52.md) - 2025-03-31 to 2025-06-30 | quarterly_net_income | -139,587,000 United States dollar | superseded | [clm_5EA972ECBC35](/claim/clm_5EA972ECBC35.md) - 2025-03-31 to 2025-06-30 | quarterly_operating_income | -193,846,000 United States dollar | superseded | [clm_CA7205182848](/claim/clm_CA7205182848.md) - 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 424,165,000 United States dollar | superseded | [clm_8E5645860D04](/claim/clm_8E5645860D04.md) - 2025-03-31 to 2025-06-30 | quarterly_revenue | 1,363,217,000 United States dollar | superseded | [clm_28E529AEECA3](/claim/clm_28E529AEECA3.md) - 2025-03-31 to 2025-06-30 | total_assets | 7,589,200,000 United States dollar | superseded | [clm_3782CE7C5E2F](/claim/clm_3782CE7C5E2F.md) - 2025-03-31 to 2025-06-30 | total_equity | 2,311,335,000 United States dollar | superseded | [clm_03317CB75395](/claim/clm_03317CB75395.md) - 2025-06-30 to 2025-09-30 | cash_and_equivalents | 925,973,000 United States dollar | superseded | [clm_AC92B7D7BE5C](/claim/clm_AC92B7D7BE5C.md) - 2025-06-30 to 2025-09-30 | quarterly_net_income | -262,570,000 United States dollar | superseded | [clm_436ACE7CCD94](/claim/clm_436ACE7CCD94.md) - 2025-06-30 to 2025-09-30 | quarterly_operating_income | -259,676,000 United States dollar | superseded | [clm_ABCEAC07EBF6](/claim/clm_ABCEAC07EBF6.md) - 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 443,325,000 United States dollar | superseded | [clm_C4C530805F4E](/claim/clm_C4C530805F4E.md) - 2025-06-30 to 2025-09-30 | quarterly_revenue | 1,344,930,000 United States dollar | superseded | [clm_1D6DFEFFAAB0](/claim/clm_1D6DFEFFAAB0.md) - 2025-06-30 to 2025-09-30 | total_assets | 7,398,987,000 United States dollar | superseded | [clm_D067FD157D2D](/claim/clm_D067FD157D2D.md) - 2025-06-30 to 2025-09-30 | total_equity | 2,069,357,000 United States dollar | superseded | [clm_8ADE423032F5](/claim/clm_8ADE423032F5.md) - 2025-09-30 to 2025-12-31 | cash_and_equivalents | 953,317,000 United States dollar | superseded | [clm_C554FC70F06C](/claim/clm_C554FC70F06C.md) - 2025-09-30 to 2026-03-31 | quarterly_net_income | -103,541,000 United States dollar | superseded | [clm_90392B5C3213](/claim/clm_90392B5C3213.md) - 2025-09-30 to 2026-03-31 | quarterly_operating_income | -128,362,000 United States dollar | superseded | [clm_08277971A6A6](/claim/clm_08277971A6A6.md) - 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 453,418,000 United States dollar | superseded | [clm_F287654B1F10](/claim/clm_F287654B1F10.md) - 2025-09-30 to 2026-03-31 | quarterly_revenue | 1,506,839,000 United States dollar | superseded | [clm_20F7A8A54662](/claim/clm_20F7A8A54662.md) - 2025-09-30 to 2025-12-31 | total_assets | 7,577,950,000 United States dollar | superseded | [clm_DACEEB2E996F](/claim/clm_DACEEB2E996F.md) - 2025-09-30 to 2025-12-31 | total_equity | 2,227,350,000 United States dollar | superseded | [clm_587D6C27628F](/claim/clm_587D6C27628F.md) - 2025-12-31 to 2026-03-31 | cash_and_equivalents | 1,030,435,000 United States dollar | superseded | [clm_DEE86D18C65E](/claim/clm_DEE86D18C65E.md) - 2025-12-31 | net_income | -460,489,000 United States dollar | valid | [clm_39D02D1FF938](/claim/clm_39D02D1FF938.md) - 2025-12-31 | operating_income | -532,167,000 United States dollar | valid | [clm_6656732F6E21](/claim/clm_6656732F6E21.md) - 2025-12-31 | research_and_development | 1,793,601,000 United States dollar | valid | [clm_71C914BD75C9](/claim/clm_71C914BD75C9.md) - 2025-12-31 | revenue | 5,931,447,000 United States dollar | valid | [clm_5EA4843BEC86](/claim/clm_5EA4843BEC86.md) - 2025-12-31 to 2026-03-31 | total_assets | 7,677,802,000 United States dollar | superseded | [clm_3828961AFE60](/claim/clm_3828961AFE60.md) - 2025-12-31 to 2026-03-31 | total_equity | 2,281,495,000 United States dollar | superseded | [clm_FE080037151A](/claim/clm_FE080037151A.md) ## 2026 - 2026-03-31 to 2026-06-30 | cash_and_equivalents | 1,061,924,000 United States dollar | superseded | [clm_5403CBA5961A](/claim/clm_5403CBA5961A.md) - 2026-03-31 to 2026-06-30 | quarterly_net_income | -88,951,000 United States dollar | superseded | [clm_C38206C2DFFB](/claim/clm_C38206C2DFFB.md) - 2026-03-31 to 2026-06-30 | quarterly_operating_income | -74,449,000 United States dollar | superseded | [clm_A785BBAA3993](/claim/clm_A785BBAA3993.md) - 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 478,296,000 United States dollar | superseded | [clm_6246A7D08FDA](/claim/clm_6246A7D08FDA.md) - 2026-03-31 to 2026-06-30 | quarterly_revenue | 1,528,791,000 United States dollar | superseded | [clm_8AD95915B90F](/claim/clm_8AD95915B90F.md) - 2026-03-31 to 2026-06-30 | total_assets | 7,501,571,000 United States dollar | superseded | [clm_5B9532481CEE](/claim/clm_5B9532481CEE.md) - 2026-03-31 to 2026-06-30 | total_equity | 2,084,273,000 United States dollar | superseded | [clm_D90490B2E30F](/claim/clm_D90490B2E30F.md) - 2026-05-09 | cfo | Douglas Hott | valid | [clm_572D7056D701](/claim/clm_572D7056D701.md) - 2026-06-30 | cash_and_equivalents | 958,848,000 United States dollar | valid | [clm_0EB8CB443BA3](/claim/clm_0EB8CB443BA3.md) - 2026-06-30 | quarterly_net_income | -163,960,000 United States dollar | valid | [clm_5E69D9C5070D](/claim/clm_5E69D9C5070D.md) - 2026-06-30 | quarterly_operating_income | -170,721,000 United States dollar | valid | [clm_DF976AE06D95](/claim/clm_DF976AE06D95.md) - 2026-06-30 | quarterly_research_and_development | 542,092,000 United States dollar | valid | [clm_976B3D3E8932](/claim/clm_976B3D3E8932.md) - 2026-06-30 | quarterly_revenue | 1,598,993,000 United States dollar | valid | [clm_5BF52DE42711](/claim/clm_5BF52DE42711.md) - 2026-06-30 | total_assets | 7,470,160,000 United States dollar | valid | [clm_20FA4B2A0A08](/claim/clm_20FA4B2A0A08.md) - 2026-06-30 | total_equity | 1,927,088,000 United States dollar | valid | [clm_E64EB29C5F94](/claim/clm_E64EB29C5F94.md) ## undated - undated | cik | 0001564408 | valid | [clm_A9FDE052F9ED](/claim/clm_A9FDE052F9ED.md) - undated | fiscal_year_end | 12-31 | valid | [clm_7AC17E0E7E29](/claim/clm_7AC17E0E7E29.md) - undated | headquarters | Santa Monica | valid | [clm_87638DD0708D](/claim/clm_87638DD0708D.md) - undated | listed_on | NYSE | valid | [clm_64B172E572CD](/claim/clm_64B172E572CD.md) - undated | sic_industry | Services-Computer Programming, Data Processing, Etc. (7370) | valid | [clm_60C0818D16DE](/claim/clm_60C0818D16DE.md) - undated | state_of_incorporation | DE | valid | [clm_3F4000830123](/claim/clm_3F4000830123.md) - undated | ticker | SNAP | valid | [clm_5465A13C7271](/claim/clm_5465A13C7271.md) - undated to 2018-08-07 | headquarters | Venice | superseded | [clm_1469B90E4033](/claim/clm_1469B90E4033.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.